DOCSLIB.ORG

Non-Coding Rnas in Muscle Differentiation and Musculoskeletal Disease

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Non-Coding Rnas in Muscle Differentiation and Musculoskeletal Disease Non-coding RNAs in muscle differentiation and musculoskeletal disease Monica Ballarino, … , Alessandro Fatica, Irene Bozzoni J Clin Invest. 2016;126(6):2021-2030. https://doi.org/10.1172/JCI84419. Review RNA is likely to be the most rediscovered macromolecule in biology. Periodically, new non-canonical functions have been ascribed to RNA, such as the ability to act as a catalytic molecule or to work independently from its coding capacity. Recent annotations show that more than half of the transcriptome encodes for RNA molecules lacking coding activity. Here we illustrate how these transcripts affect skeletal muscle differentiation and related disorders. We discuss the most recent scientific discoveries that have led to the identification of the molecular circuitries that are controlled by RNA during the differentiation process and that, when deregulated, lead to pathogenic events. These findings will provide insights that can aid in the development of new therapeutic interventions for muscle diseases. Find the latest version: https://jci.me/84419/pdf The Journal of Clinical Investigation REVIEW Non-coding RNAs in muscle differentiation and musculoskeletal disease Monica Ballarino,1,2 Mariangela Morlando,1 Alessandro Fatica,1 and Irene Bozzoni1,2,3 1Department of Biology and Biotechnology Charles Darwin and 2Institute Pasteur Fondazione Cenci-Bolognetti, Sapienza University of Rome, Rome, Italy. 3Center for Life Nano Science@Sapienza, Istituto Italiano di Tecnologia, Rome, Italy. RNA is likely to be the most rediscovered macromolecule in biology. Periodically, new non-canonical functions have been ascribed to RNA, such as the ability to act as a catalytic molecule or to work independently from its coding capacity. Recent annotations show that more than half of the transcriptome encodes for RNA molecules lacking coding activity. Here we illustrate how these transcripts affect skeletal muscle differentiation and related disorders. We discuss the most recent scientific discoveries that have led to the identification of the molecular circuitries that are controlled by RNA during the differentiation process and that, when deregulated, lead to pathogenic events. These findings will provide insights that can aid in the development of new therapeutic interventions for muscle diseases. Non-coding RNAs (ncRNAs) include different families of tran- tides, while miR-133a-1 and miR-133a-2 are identical and differ scripts of both small (sncRNA) and large (lncRNA) sizes. The from miR-133b by 2 nucleotides. Moreover, they are organized in impact of these molecules in the control of cell development, dif- duplicated clusters (miR-1-1/miR-133a-1 and miR-1-2/miR-133a-2) ferentiation, and growth has now been established, and it is clear that in vertebrates also originated the miR-206/miR-133b locus. that these molecules exert their functions in both nuclear and cyto- While mice lacking only one of the two miR-1 or miR-133 copies plasmic compartments (1). Muscle differentiation has been one of displayed minor defects, mainly of cardiac type, deletion of both the most exploited and studied processes due to the availability of copies resulted in lethality (9, 10). Conversely, deletion of the suitable cellular systems that faithfully recapitulate in vivo differ- regenerative miR-206 in mice substantially delayed regeneration entiation and animal models for different muscle diseases (2–4). induced by cardiotoxin injury (11). Alterations in myogenesis may underlie many muscle disor- Figure 1 summarizes the most relevant circuits controlled by ders, including sarcopenia, cachexia, and muscular dystrophies, miRNAs in skeletal muscle cells. miRNAs can target transcription where alterations in regenerative capacity play a crucial role in factors, either promoting or inhibiting myogenesis. Conversely, disease progression and outcome. Moreover, perturbation of reg- these same transcription factors can directly control expression of ulatory circuits controlling muscle homeostasis are involved in these miRNAs through regulatory feedback loops (9, 12, 13). structural and functional changes that occur during muscle atro- Deregulation of miRNA expression is a common feature of phy and hypertrophy; therefore, the identification of new compo- several skeletal muscle disorders, and rescue of their correct nents controlling muscle differentiation and regeneration could expression in mouse models ameliorates disease phenotypes clarify the molecular pathogenic mechanisms in different diseases (11, 14, 15). miRNA profiles of different skeletal muscle disorders and potentially allow the identification of new therapeutic targets. (16–21) revealed that, despite their heterogeneity, these disorders share a common set of deregulated miRNAs, which generally MicroRNAs includes myomiRs. MicroRNAs (miRNAs) play important roles in all the steps of Duchenne muscular dystrophy (DMD), the most common myogenesis. Additionally, the molecular circuits controlled by and severe muscular disease characterized by mutations in the miRNAs have been largely characterized (5). During myogenesis dystrophin gene, provides a relevant example of disease-linked an intricate relationship between miRNAs and myogenic factors miRNA activity that is involved in pathogenic circuits. Besides is established, with miRNAs acting synergistically or antagonis- serving as a structural protein that protects muscle fibers from tically. miR-1, miR-133, miR-206, miR-499, and miR-208 are the mechanical damage, dystrophin controls the switch from early to so-called myomiRs because their expression is restricted to skel- late phases of differentiation, acting as an epigenetic modulator etal and/or cardiac muscles (6–8). Notably, the major myomiRs of gene expression through a pathway involving neuronal NOS have an interesting evolutionary and genomic correlation: miR-1-1 (nNOS) and histone deacetylase 2 (HDAC2) (22, 23). In normal and miR-1-2 are identical and differ from miR-206 by 4 nucleo- muscle, dystrophin activates nNOS, which in turn nitrosylates HDAC2, leading to its release from the chromatin of specific tar- get genes to drive transcriptional activation. Several miRNA genes Conflict of interest: The authors have declared that no conflict of interest exists. were identified as targets of this pathway, including miRNAs Reference information: J Clin Invest. 2016;126(6):2021–2030. doi:10.1172/JCI84419. involved in terminal differentiation of muscle, such as miR-1 and jci.org Volume 126 Number 6 June 2016 2021 REVIEW The Journal of Clinical Investigation Figure 1. miRNA-mediated regulatory networks in myogenesis and skeletal muscle diseases. Schematic representation of the differentiation stages leading from progenitor muscle cells to terminally differentiated fibers. The most relevant regulatory circuits between miRNAs and protein factors are shown. miRNA species that are up- or downregulated in dystrophic cells are represented in red and green, respectively. Polα, polymerase α. miR-133, and the more ubiquitous miR-29 and miR-30 (17). In phic phenotype (11), while sustained expression of miR-206 pro- dystrophic muscles, the absence of dystrophin disrupts such cir- moted satellite cell differentiation and fusion, suggesting that the cuitry, leading to reduced levels of specific miRNAs, which favors strong activation of miR-206 in dystrophic muscles induces com- the onset of dystrophic pathogenic traits such as oxidative dam- pensatory circuits to promote the formation of new myofibers in age through upregulation of the miR-1 target glucose-6-phos- response to disease-induced injury. This activity is mediated at the phate dehydrogenase (G6PD) and fibrosis through deregulation molecular level through suppression of several negative regulators of the collagen mRNAs targeted by miR-29 (17, 24, 25) (Figure 1). of myogenesis, including paired box protein–7 (PAX7), Notch3, Notably, both miR-1 and miR-29, which are poorly expressed in and insulin-like growth factor–binding protein–5 (IGFBP5) (11, 17). murine and human dystrophic muscles, were recovered in exon miR-206 is also linked to amyotrophic lateral sclerosis (ALS). skipping–treated mdx mice (a murine model of DMD) and DMD Expression of miR-206 was dramatically increased in an ALS myoblasts (17). Moreover, these miRNAs were downregulated mouse model where pathological alterations are first detected in in individuals with Becker muscular dystrophy (BMD), in which muscle, particularly at the neuromuscular junction (NMJ) prior mutant dystrophin cannot bind nNOS (26). In line with these to motor neuron loss (30). miR-206 was shown to be required findings, epigenetic control mediated by HDACs was identified for efficient regeneration of neuromuscular synapses after acute as a major regulatory effector in promoting muscle regeneration nerve injury, and its genetic deletion accelerated disease progres- (22, 27) and a relevant epigenetic HDAC/myomiR network was sion and diminished survival. Therefore, miR-206 was suggested recently shown to target the transcriptional regulators BRG1- to slow ALS progression by sensing motor neuron injury and pro- associated factor 60A and 60B (BAF60A and BAF60B), ulti- moting the compensatory regeneration of neuromuscular syn- mately directing promyogenic differentiation while suppressing apses (14). Two important downstream targets are likely involved the fibro-adipogenic phenotype (28). in this pathway: HDAC4, which has been implicated in the con- miR-1 shares a seed sequence with another myomiR, miR- trol of neuromuscular gene expression
Load more

Recommended publications
  • Recognition of Cancer Mutations in Histone H3K36 by Epigenetic Writers and Readers Brianna J
    EPIGENETICS https://doi.org/10.1080/15592294.2018.1503491 REVIEW Recognition of cancer mutations in histone H3K36 by epigenetic writers and readers Brianna J. Kleina, Krzysztof Krajewski b, Susana Restrepoa, Peter W. Lewis c, Brian D. Strahlb, and Tatiana G. Kutateladzea aDepartment of Pharmacology, University of Colorado School of Medicine, Aurora, CO, USA; bDepartment of Biochemistry & Biophysics, The University of North Carolina School of Medicine, Chapel Hill, NC, USA; cWisconsin Institute for Discovery, University of Wisconsin, Madison, WI, USA ABSTRACT ARTICLE HISTORY Histone posttranslational modifications control the organization and function of chromatin. In Received 30 May 2018 particular, methylation of lysine 36 in histone H3 (H3K36me) has been shown to mediate gene Revised 1 July 2018 transcription, DNA repair, cell cycle regulation, and pre-mRNA splicing. Notably, mutations at or Accepted 12 July 2018 near this residue have been causally linked to the development of several human cancers. These KEYWORDS observations have helped to illuminate the role of histones themselves in disease and to clarify Histone; H3K36M; cancer; the mechanisms by which they acquire oncogenic properties. This perspective focuses on recent PTM; methylation advances in discovery and characterization of histone H3 mutations that impact H3K36 methyla- tion. We also highlight findings that the common cancer-related substitution of H3K36 to methionine (H3K36M) disturbs functions of not only H3K36me-writing enzymes but also H3K36me-specific readers. The latter case suggests that the oncogenic effects could also be linked to the inability of readers to engage H3K36M. Introduction from yeast to humans and has been shown to have a variety of functions that range from the control Histone proteins are main components of the of gene transcription and DNA repair, to cell cycle nucleosome, the fundamental building block of regulation and nutrient stress response [8].
    [Show full text]
  • Screening for Genes That Accelerate the Epigenetic Aging Clock in Humans Reveals a Role for the H3K36 Methyltransferase NSD1 Daniel E
    Martin-Herranz et al. Genome Biology (2019) 20:146 https://doi.org/10.1186/s13059-019-1753-9 RESEARCH Open Access Screening for genes that accelerate the epigenetic aging clock in humans reveals a role for the H3K36 methyltransferase NSD1 Daniel E. Martin-Herranz1,2* , Erfan Aref-Eshghi3,4, Marc Jan Bonder1,5, Thomas M. Stubbs2, Sanaa Choufani6, Rosanna Weksberg6, Oliver Stegle1,5,7, Bekim Sadikovic3,4, Wolf Reik8,9,10*† and Janet M. Thornton1*† Abstract Background: Epigenetic clocks are mathematical models that predict the biological age of an individual using DNA methylation data and have emerged in the last few years as the most accurate biomarkers of the aging process. However, little is known about the molecular mechanisms that control the rate of such clocks. Here, we have examined the human epigenetic clock in patients with a variety of developmental disorders, harboring mutations in proteins of the epigenetic machinery. Results: Using the Horvath epigenetic clock, we perform an unbiased screen for epigenetic age acceleration in the blood of these patients. We demonstrate that loss-of-function mutations in the H3K36 histone methyltransferase NSD1, which cause Sotos syndrome, substantially accelerate epigenetic aging. Furthermore, we show that the normal aging process and Sotos syndrome share methylation changes and the genomic context in which they occur. Finally, we found that the Horvath clock CpG sites are characterized by a higher Shannon methylation entropy when compared with the rest of the genome, which is dramatically decreased in Sotos syndrome patients. Conclusions: These results suggest that the H3K36 methylation machinery is a key component of the epigenetic maintenance system in humans, which controls the rate of epigenetic aging, and this role seems to be conserved in model organisms.
    [Show full text]
  • Chromatin Dynamics During DNA Replication Raz Bar-Ziv*, Yoav Voichek* and Naama Barkai†
    Downloaded from genome.cshlp.org on October 5, 2021 - Published by Cold Spring Harbor Laboratory Press Chromatin Dynamics during DNA Replication Raz Bar-Ziv*, Yoav Voichek* and Naama Barkai† Affiliations: Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel. *these authors contributed equally to the manuscript †Correspondence to: [email protected] Keywords: Chromatin; Replication; Summary: Chromatin is composed of DNA and histones, which provide a unified platform for regulating DNA-related processes, mostly through their post translational modification. During DNA replication, histone arrangement is perturbed, to first allow progression of DNA polymerase and then during repackaging of the replicated DNA. To study how DNA replication influences the pattern of histone modification, we followed the cell-cycle dynamics of ten histone marks in budding yeast. We find that histones deposited on newly replicated DNA are modified at different rates; while some marks appear immediately upon replication (e.g. H4K16ac, H3K4me1), others increase with transcription-dependent delays (e.g. H3K4me3, H3K36me3). Notably, H3K9ac was deposited as a wave preceding the replication fork by ~5-6 kb. This replication-guided H3K9ac was fully dependent on the acetyltransferase Rtt109, while expression-guided H3K9ac was deposited by Gcn5. Further, topoisomerase depletion intensified H3K9ac in front of the replication fork, and in sites where RNA polymerase II was trapped, suggesting supercoiling stresses trigger H3K9 acetylation. Our results assign complementary roles for DNA replication and gene expression in defining the pattern of histone modification. Introduction: In eukaryotic cells, DNA is wrapped around histone octamers to form nucleosomes, the basic building blocks of the chromatin structure.
    [Show full text]
  • H3K36 Methylation Reprograms Gene Expression to Drive Early Gametocyte Development in Plasmodium Falciparum Jessica Connacher1, Gabrielle A
    Connacher et al. Epigenetics & Chromatin (2021) 14:19 https://doi.org/10.1186/s13072-021-00393-9 Epigenetics & Chromatin RESEARCH Open Access H3K36 methylation reprograms gene expression to drive early gametocyte development in Plasmodium falciparum Jessica Connacher1, Gabrielle A. Josling2, Lindsey M. Orchard2, Janette Reader1, Manuel Llinás2,3 and Lyn‑Marié Birkholtz1* Abstract Background: The Plasmodium sexual gametocyte stages are the only transmissible form of the malaria parasite and are thus responsible for the continued transmission of the disease. Gametocytes undergo extensive functional and morphological changes from commitment to maturity, directed by an equally extensive control program. However, the processes that drive the diferentiation and development of the gametocyte post‑commitment, remain largely unexplored. A previous study reported enrichment of H3K36 di‑ and tri‑methylated (H3K36me2&3) histones in early‑ stage gametocytes. Using chromatin immunoprecipitation followed by high‑throughput sequencing, we identify a stage‑specifc association between these repressive histone modifcations and transcriptional reprogramming that defne a stage II gametocyte transition point. Results: Here, we show that H3K36me2 and H3K36me3 from stage II gametocytes are associated with repression of genes involved in asexual proliferation and sexual commitment, indicating that H3K36me2&3‑mediated repression of such genes is essential to the transition from early gametocyte diferentiation to intermediate development. Impor‑ tantly, we show that the gene encoding the transcription factor AP2‑G as commitment master regulator is enriched with H3K36me2&3 and actively repressed in stage II gametocytes, providing the frst evidence of ap2-g gene repres‑ sion in post‑commitment gametocytes. Lastly, we associate the enhanced potency of the pan‑selective Jumonji inhibitor JIB‑04 in gametocytes with the inhibition of histone demethylation including H3K36me2&3 and a disruption of normal transcriptional programs.
    [Show full text]
  • New Insights Into the Role of Histone Changes in Aging
    International Journal of Molecular Sciences Review New Insights into the Role of Histone Changes in Aging Sun-Ju Yi and Kyunghwan Kim * Department of Biology, School of Biological Sciences, College of Natural Sciences, Chungbuk National University, Cheongju 28644, Chungbuk, Korea; [email protected] * Correspondence: [email protected]; Tel.: +82-(43)-2612292 Received: 14 October 2020; Accepted: 2 November 2020; Published: 3 November 2020 Abstract: Aging is the progressive decline or loss of function at the cellular, tissue, and organismal levels that ultimately leads to death. A number of external and internal factors, including diet, exercise, metabolic dysfunction, genome instability, and epigenetic imbalance, affect the lifespan of an organism. These aging factors regulate transcriptome changes related to the aging process through chromatin remodeling. Many epigenetic regulators, such as histone modification, histone variants, and ATP-dependent chromatin remodeling factors, play roles in chromatin reorganization. The key to understanding the role of gene regulatory networks in aging lies in characterizing the epigenetic regulators responsible for reorganizing and potentiating particular chromatin structures. This review covers epigenetic studies on aging, discusses the impact of epigenetic modifications on gene expression, and provides future directions in this area. Keywords: aging; histone level; histone modification; histone variant; chromatin remodeling; epigenetics 1. Introduction An individual organism undergoes a series of developmental stages, including birth, growth, maturity, aging, and death. Aging is the gradual and continuous decline or loss of function at the cellular, tissue, and organismal levels with the passage of time. Aging is considered to begin in early adulthood, but is regarded as an integral part of life since other stages also affect the aging process [1].
    [Show full text]
  • Epigenetic Consequences of in Utero Exposure to Rosuvastatin: Alteration of Histone Methylation Patterns in Newborn Rat Brains
    International Journal of Molecular Sciences Article Epigenetic Consequences of in Utero Exposure to Rosuvastatin: Alteration of Histone Methylation Patterns in Newborn Rat Brains Karolina Dulka 1, Melinda Szabo 1, Noémi Lajkó 1, István Belecz 2, Zsófia Hoyk 3 and Karoly Gulya 1,* 1 Department of Cell Biology and Molecular Medicine, University of Szeged, 6720 Szeged, Hungary; [email protected] (K.D.); [email protected] (M.S.); [email protected] (N.L.) 2 Department of Medical Biology, University of Szeged, 6720 Szeged, Hungary; [email protected] 3 Biological Barriers Research Group, Institute of Biophysics, Biological Research Center, Eötvös Loránd Research Network, 6726 Szeged, Hungary; hoyk.zsofi[email protected] * Correspondence: [email protected] Abstract: Rosuvastatin (RST) is primarily used to treat high cholesterol levels. As it has potentially harmful but not well-documented effects on embryos, RST is contraindicated during pregnancy. To demonstrate whether RST could induce molecular epigenetic events in the brains of newborn rats, pregnant mothers were treated daily with oral RST from the 11th day of pregnancy for 10 days (or until delivery). On postnatal day 1, the brains of the control and RST-treated rats were removed for Western blot or immunohistochemical analyses. Several antibodies that recognize different methylation sites for H2A, H2B, H3, and H4 histones were quantified. Analyses of cell-type-specific markers in the newborn brains demonstrated that prenatal RST administration did not affect the composition and cell type ratios as compared to the controls. Prenatal RST administration did, Citation: Dulka, K.; Szabo, M.; however, induce a general, nonsignificant increase in H2AK118me1, H2BK5me1, H3, H3K9me3, Lajkó, N.; Belecz, I.; Hoyk, Z.; Gulya, K.
    [Show full text]
  • Histone Methylation by PRC2 Is Inhibited by Active Chromatin Marks
    Molecular Cell Article Histone Methylation by PRC2 Is Inhibited by Active Chromatin Marks Frank W. Schmitges,1,6 Archana B. Prusty,2,6 Mahamadou Faty,1 Alexandra Stu¨tzer,3 Gondichatnahalli M. Lingaraju,1 Jonathan Aiwazian,1 Ragna Sack,1 Daniel Hess,1 Ling Li,4 Shaolian Zhou,4 Richard D. Bunker,1 Urs Wirth,5 Tewis Bouwmeester,5 Andreas Bauer,5 Nga Ly-Hartig,2 Kehao Zhao,4 Homan Chan,4 Justin Gu,4 Heinz Gut,1 Wolfgang Fischle,3 Ju¨rgMu¨ ller,2,7,* and Nicolas H. Thoma¨ 1,* 1Friedrich Miescher Institute for Biomedical Research, Maulbeerstrasse 66, CH-4058 Basel, Switzerland 2Genome Biology Unit, EMBL Heidelberg, Meyerhofstrasse 1, D-69117 Heidelberg, Germany 3Laboratory of Chromatin Biochemistry, Max Planck Institute for Biophysical Chemistry, Am Fassberg 11, D-37077 Go¨ ttingen, Germany 4China Novartis Institutes for Biomedical Research, Lane 898 Halei Road, Zhangjiang, Shanghai, China 5Novartis Institutes for Biomedical Research, CH-4002 Basel, Switzerland 6These authors contributed equally to this work 7Present address: Max Planck Institute of Biochemistry, Am Klopferspitz 18, D-82152 Martinsried, Germany *Correspondence: [email protected] (J.M.), [email protected] (N.H.T.) DOI 10.1016/j.molcel.2011.03.025 SUMMARY keep the same genes active in cells where they must be expressed. The Polycomb repressive complex 2 (PRC2) confers Among the PcG protein complexes, Polycomb repressive transcriptional repression through histone H3 lysine complex 2 (PRC2) is a histone methyl-transferase (HMTase) 27 trimethylation (H3K27me3). Here, we examined that methylates Lys27 of H3 (H3K27) (Cao et al., 2002; Czermin how PRC2 is modulated by histone modifications et al., 2002; Kuzmichev et al., 2004; Mu¨ ller et al., 2002).
    [Show full text]
  • Cycles of Gene Expression and Genome Response During
    Rib et al. Epigenetics & Chromatin (2018) 11:52 https://doi.org/10.1186/s13072-018-0222-0 Epigenetics & Chromatin RESEARCH Open Access Cycles of gene expression and genome response during mammalian tissue regeneration Leonor Rib1,2,3, Dominic Villeneuve1, Shilpi Minocha1, Viviane Praz1,2, Nouria Hernandez1, Nicolas Guex2*, Winship Herr1* and The CycliX Consortium Abstract Background: Compensatory liver hyperplasia—or regeneration—induced by two-thirds partial hepatectomy (PH) permits the study of synchronized activation of mammalian gene expression, particularly in relation to cell prolifera- tion. Here, we measured genomic transcriptional responses and mRNA accumulation changes after PH and sham surgeries. Results: During the frst 10–20 h, the PH- and sham-surgery responses were very similar, including parallel early activation of cell-division-cycle genes. After 20 h, however, whereas post-PH livers continued with a robust and coor- dinate cell-division-cycle gene-expression response before returning to the resting state by 1 week, sham-surgery livers returned directly to a resting gene-expression state. Localization of RNA polymerase II (Pol II), and trimethylated histone H3 lysine 4 (H3K4me3) and 36 (H3K36me3) on genes dormant in the resting liver and activated during the PH response revealed a general de novo promoter Pol II recruitment and H3K4me3 increase during the early 10–20 h phase followed by Pol II elongation and H3K36me3 accumulation in gene bodies during the later proliferation phase. H3K36me3, generally appearing at the frst internal exon, was preceded 5′ by H3K36me2; 3′ of the frst internal exon, in about half of genes H3K36me3 predominated and in the other half H3K36me2 and H3K36me3 co-existed.
    [Show full text]
  • Global Regulation of the Histone Mark H3k36me2 Underlies Epithelial Plasticity and Metastatic Progression
    Author Manuscript Published OnlineFirst on March 18, 2020; DOI: 10.1158/2159-8290.CD-19-1299 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Global regulation of the histone mark H3K36me2 underlies epithelial plasticity and metastatic progression Salina Yuan1, 2, 3, Ramakrishnan Natesan3, 4, 5, Francisco J. Sanchez-Rivera7, Jinyang Li1, 2, 3, Natarajan V. Bhanu5, 6, Taiji Yamazoe1, 2, 3, Jeffrey H. Lin1, 3, Allyson J. Merrell1, 2, 3, Yogev Sela1, 2, 3, Stacy K. Thomas1, 3, Yanqing Jiang3, 4, Jacqueline B. Plesset3, 4, Emma M. Miller8, Junwei Shi3, 4, 5, Ben A. Garcia5, 6, Scott W. Lowe7, 9, Irfan A. Asangani3, 4, 5, and Ben Z. Stanger1, 2, 3, 10 1Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA. 2Department of Cell and Developmental Biology, University of Pennsylvania, Philadelphia, PA, USA. 3Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA, USA. 4Department of Cancer Biology, University of Pennsylvania, Philadelphia, PA, USA. 5Penn Epigenetics Institute, University of Pennsylvania, Philadelphia, PA, USA. 6Department of Biochemistry and Molecular Biophysics, University of Pennsylvania, Philadelphia, PA, USA. 7Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 8Haverford College, Haverford, Pennsylvania, PA, USA. 9Howard Hughes Medical Institute, New York, NY, USA. Running Title: Epigenomic control of epithelial plasticity and metastasis Keywords: Cellular plasticity, metastasis, epigenetics, histone modifications, EMT This work was supported by NIH grants CA229803 and DK083355 (BZS), CA224970 (SY), CA196539 and AI118891 (BAG), CA249210 (IAA), a V Foundation Translational award (BZS), a Leukemia and Lymphoma Robert Arceci Award (BAG), and DOD W81XWH-17-1-0404 (IAA), the Abramson Family Cancer Research Institute, the Abramson Cancer Center, and the NIH/Penn Center for Molecular Studies in Digestive and Liver Diseases.
    [Show full text]
  • The DNMT3A PWWP Domain Is Essential for the Normal DNA Methylation Landscape in Mouse Somatic Cells and Oocytes
    RESEARCH ARTICLE The DNMT3A PWWP domain is essential for the normal DNA methylation landscape in mouse somatic cells and oocytes 1 1,2 1,3 1 1 Kanako Kibe , Kenjiro ShiraneID , Hiroaki OhishiID , Shuhei UemuraID , Hidehiro Toh , Hiroyuki Sasaki1* 1 Division of Epigenomics and Development, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan, 2 Department of Stem Cell Biology and Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan, 3 Graduate School of Integrated Science for Life, Hiroshima University, Higashi- a1111111111 Hiroshima, Japan a1111111111 a1111111111 * [email protected] a1111111111 a1111111111 Abstract DNA methylation at CG sites is important for gene regulation and embryonic development. In mouse oocytes, de novo CG methylation requires preceding transcription-coupled his- OPEN ACCESS tone mark H3K36me3 and is mediated by a DNA methyltransferase DNMT3A. DNMT3A Citation: Kibe K, Shirane K, Ohishi H, Uemura S, Toh H, Sasaki H (2021) The DNMT3A PWWP has a PWWP domain, which recognizes H3K36me2/3, and heterozygous mutations in this domain is essential for the normal DNA domain, including D329A substitution, cause aberrant CG hypermethylation of regions methylation landscape in mouse somatic cells and marked by H3K27me3 in somatic cells, leading to a dwarfism phenotype. We herein demon- oocytes. PLoS Genet 17(5): e1009570. https://doi. strate that D329A homozygous mice show greater CG hypermethylation and severer dwarf- org/10.1371/journal.pgen.1009570 ism. In oocytes, D329A substitution did not affect CG methylation of H3K36me2/3-marked Editor: Marisa S. Bartolomei, University of regions, including maternally methylated imprinting control regions; rather, it caused aber- Pennsylvania, UNITED STATES rant hypermethylation in regions lacking H3K36me2/3, including H3K27me3-marked Received: January 29, 2021 regions.
    [Show full text]
  • Depletion of H3k36me2 Recapitulates Epigenomic and Phenotypic Changes Induced by the H3.3K36M Oncohistone Mutation
    Depletion of H3K36me2 recapitulates epigenomic and phenotypic changes induced by the H3.3K36M oncohistone mutation Kartik N. Rajagopalana,b,1,2, Xiao Chenc,d,1, Daniel N. Weinbergb,1, Haifen Chene, Jacek Majewskie,f,3, C. David Allisb,3, and Chao Luc,d,3 aDivision of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY 10032; bLaboratory of Chromatin Biology and Epigenetics, The Rockefeller University, New York, NY 10065; cDepartment of Genetics and Development, Columbia University Irving Medical Center, New York, NY 10032; dHerbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032; eDepartment of Human Genetics, McGill University, Montreal, QC H3A 1B1, Canada; and fMcGill Genome Centre, Montreal, QC H3A 0G1, Canada Contributed by C. David Allis, January 15, 2021 (sent for review October 19, 2020; reviewed by Sharon Y. R. Dent, Brian D. Strahl, and Johnathan Whetstine) Hotspot histone H3 mutations have emerged as drivers of onco- H3K36 methylation in tissue homeostasis and tumorigenesis. genesis in cancers of multiple lineages. Specifically, H3 lysine 36 to The reprogramming of the transcriptome by the H3K36M mu- methionine (H3K36M) mutations are recurrently identified in tation appears to be coupled to the redistribution of another chondroblastomas, undifferentiated sarcomas, and head and neck histone modification, H3K27 trimethylation (H3K27me3) (10, cancers. While the mutation reduces global levels of both H3K36 11, 13). H3K36 methylation is known to antagonize the activity dimethylation (H3K36me2) and trimethylation (H3K36me3) by of polycomb repressive complex 2 (PRC2)—the methyl- dominantly inhibiting their respective specific methyltransferases, transferase for H3K27me3 (14, 15).
    [Show full text]
  • Regulating Methylation at H3K27: a Trick Or Treat for Cancer Cell Plasticity
    cancers Review Regulating Methylation at H3K27: A Trick or Treat for Cancer Cell Plasticity Provas Das and Joseph H. Taube * Department of Biology, Baylor University, Waco, TX 76706, USA; [email protected] * Correspondence: [email protected] Received: 29 August 2020; Accepted: 23 September 2020; Published: 29 September 2020 Simple Summary: Regulation of gene expression is important for appropriate cell development but can also lead to inappropriate cell transformation resulting in cancer. Modification to the proteins that wrap DNA is essential for regulating gene expression. Mutations in the enzymes that modify such proteins are being discovered in many cancers. This review will cover present knowledge of these enzymes as they relate to cancer initiation and progression. Abstract: Properly timed addition and removal of histone 3 lysine 27 tri-methylation (H3K27me3) is critical for enabling proper differentiation throughout all stages of development and, likewise, can guide carcinoma cells into altered differentiation states which correspond to poor prognoses and treatment evasion. In early embryonic stages, H3K27me3 is invoked to silence genes and restrict cell fate. Not surprisingly, mutation or altered functionality in the enzymes that regulate this pathway results in aberrant methylation or demethylation that can lead to malignancy. Likewise, changes in expression or activity of these enzymes impact cellular plasticity, metastasis, and treatment evasion. This review focuses on current knowledge regarding methylation and de-methylation of H3K27 in cancer initiation and cancer cell plasticity. Keywords: H3K27me3; EZH2; KDM6A; KDM6B; cancer cell plasticity 1. Introduction Regulation of gene expression depends on access to the genome and recruitment of trans-acting factors, both of which are processes that are impacted by the histone modification state.
    [Show full text]